Read Simon Insider Trades

Insider Trading History

Track insider trading activity for Read Simon. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $0 0 shares
Last Trade
Aug 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$327k 2,778 shares
$117.55
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $245k 2,778 shares
Last Trade
Aug 19, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$319k 2,778 shares
$114.86
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $1.72M 19,445 shares
Last Trade
Aug 19, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$319k 2,778 shares
$114.86
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $239k 2,707 shares
Last Trade
Aug 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$304k 2,777 shares
$109.56
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $245k 2,777 shares
Last Trade
Aug 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$310k 2,777 shares
$111.80
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $1.96M 22,223 shares
Last Trade
Aug 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$310k 2,777 shares
$111.80
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $537k 6,090 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 6,090 shares
$89.63
$88.21
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $2.21M 25,000 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$459k 25,000 shares
$18.36
$88.21

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up